ASK17 Antibody

Shipped with Ice Packs
In Stock

Description

ASK1 Antibody Overview

ASK1 is a stress-activated MAP3K critical for apoptosis and inflammation regulation. Antibodies targeting ASK1 are widely used in cancer research and autoimmune disease studies.

Key Features of ASK1 Antibodies:

PropertyDetailsSource(s)
TargetASK1 (Apoptosis Signal-Regulating Kinase 1)
ApplicationsWestern Blot (WB), Immunohistochemistry (IHC), Apoptosis Signaling Studies
Species ReactivityHuman, Mouse
Molecular Weight (kDa)~155 (Human)
Functional RoleTumor suppression via proapoptotic activity in epithelial cells; regulates inflammation

Research Findings:

  • ASK1 deletion reduces apoptosis in keratinocytes, promoting tumorigenesis in ASK2−/− mice .

  • Reduced ASK2 expression correlates with esophageal squamous cell carcinoma (ESCC) progression in humans .

  • ASK1 antibodies (e.g., CST #3762) detect endogenous ASK1 in WB with high specificity .

ADAM17 Antibody Overview

ADAM17 is a metalloprotease involved in EGFR ligand shedding and tumor progression. Inhibitory antibodies against ADAM17 show therapeutic potential in cancers like pancreatic ductal adenocarcinoma (PDAC).

Key Features of ADAM17 Antibodies:

PropertyDetailsSource(s)
TargetADAM17 (A Disintegrin and Metalloproteinase 17)
ApplicationsELISA, Western Blot, Immunofluorescence, Cancer Therapy Development
Species ReactivityHuman, Mouse, Rat
Therapeutic RoleInhibits EGFR ligand shedding; suppresses tumor growth in PDAC mouse models
Notable AntibodyA9(B8) IgG: Cross-reactive antibody reducing tumorigenesis in KRAS-mutant PDAC

Research Findings:

  • A9(B8) IgG inhibits ADAM17 activity, delaying PDAC progression in preclinical models .

  • ADAM17 knockdown reduces motility in pancreatic cancer cells .

  • Anti-ADAM17 antibodies (e.g., A16782) show efficacy in immunofluorescence and IHC .

Comparative Analysis of ASK1 vs. ADAM17 Antibodies

ParameterASK1 AntibodyADAM17 Antibody
Primary RoleApoptosis regulation, tumor suppressionEGFR ligand shedding, tumor promotion inhibition
Key DiseasesAutoimmune disorders, cancerPancreatic cancer, inflammatory diseases
Therapeutic UseInvestigational (e.g., ASK1 inhibitors in trials)Preclinical (e.g., A9(B8) IgG for PDAC)
Commercial AvailabilityYes (CST #3762, R&D AF3575)Yes (A16782, A9(B8) IgG)

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
ASK17 antibody; MEO antibody; At2g20160 antibody; T2G17.4 antibody; SKP1-like protein 17 antibody; AtSK17 antibody; Protein MEIDOS antibody
Target Names
ASK17
Uniprot No.

Target Background

Function
ASK17 is involved in the ubiquitination and subsequent proteasomal degradation of target proteins. It forms part of the SCF (Skp1-Cullin-F-box protein) E3 ubiquitin ligase complex, alongside CUL1 and RBX1, and an F-box protein. The F-box protein determines the functional specificity of this complex. Within the SCF complex, ASK17 acts as an adapter, linking the F-box protein to CUL1. ASK17 is also likely implicated in the incompatibility response following hybridization.
Database Links
Protein Families
SKP1 family
Subcellular Location
Nucleus.
Tissue Specificity
Mainly detected in the siliques.

Q&A

What is ASK17 and what biological functions does it serve in Arabidopsis thaliana?

ASK17 (Uniprot accession: Q9SL65) is a member of the SKP1-like protein family in Arabidopsis thaliana. These proteins typically function as components of SCF (SKP1-CUL1-F-box) E3 ubiquitin ligase complexes that play crucial roles in protein degradation via the ubiquitin-proteasome pathway. ASK17 participates in critical cellular processes including cell cycle regulation, hormone signaling, and stress responses. The protein contains approximately 160 amino acids and features a conserved SKP1-POZ domain essential for protein-protein interactions, particularly with F-box proteins .

What are the standard applications of ASK17 antibodies in plant biology research?

ASK17 antibodies are valuable tools for multiple research applications:

  • Protein detection: Western blotting, immunoprecipitation, and ELISA for quantifying ASK17 expression levels

  • Protein localization: Immunohistochemistry (IHC) and immunofluorescence to determine subcellular and tissue distribution

  • Protein-protein interaction studies: Co-immunoprecipitation to identify binding partners

  • Chromatin immunoprecipitation (ChIP): When studying transcriptional regulatory roles

  • Flow cytometry: For cell-specific expression analysis

For immunohistochemical applications, researchers typically follow a protocol similar to that outlined for other plant proteins, involving paraffin-embedded sections, antigen retrieval, overnight primary antibody incubation at 4°C, and detection using peroxidase-conjugated secondary antibodies .

How should researchers evaluate the quality and specificity of commercial ASK17 antibodies?

Researchers should assess ASK17 antibodies through:

  • Literature validation: Review published studies that have successfully employed the antibody

  • Positive and negative controls: Use tissues with known expression patterns and knockout lines

  • Western blot analysis: Confirm single band of appropriate molecular weight

  • Cross-reactivity testing: Evaluate potential recognition of other ASK family proteins

  • Multiple detection methods: Compare results across different techniques (Western blot, IHC, etc.)

Validation MethodPurposeExpected Outcome for High-Quality ASK17 Antibody
Western blotSpecificity confirmationSingle band at ~18 kDa
ImmunohistochemistryLocalization patternStaining consistent with known expression
Knockout controlSpecificity verificationNo signal in ASK17 knockout plants
Peptide competitionBinding specificitySignal abolished when pre-incubated with immunizing peptide
Cross-reactivity analysisFamily specificityMinimal recognition of other ASK proteins

What are the key considerations for ASK17 antibody selection in experimental design?

When selecting ASK17 antibodies, researchers should consider:

  • Antibody type: Polyclonal vs. monoclonal (polyclonals offer higher sensitivity but potentially lower specificity)

  • Host species: Choose based on compatibility with existing secondary antibodies and to avoid cross-reactivity

  • Immunogen design: Antibodies raised against unique epitopes of ASK17 minimize cross-reactivity with other ASK family members

  • Application validation: Ensure the antibody is validated for your specific application (WB, IHC, IP, etc.)

  • Lot-to-lot consistency: Consider requesting the same lot for extended studies to maintain consistency

How can researchers optimize immunohistochemistry protocols for ASK17 detection in plant tissues?

For optimal ASK17 detection in plant tissues:

  • Fixation optimization: Test different fixatives (paraformaldehyde, glutaraldehyde) and durations to preserve protein structure while maintaining antigenicity

  • Antigen retrieval methods: Compare heat-induced (pressure cooker, microwave) versus enzymatic methods

  • Blocking optimization: Test different blocking agents (BSA, normal serum, commercial blockers) at various concentrations

  • Antibody titration: Establish optimal primary antibody dilutions (typically 1:100-1:1000)

  • Signal amplification: Consider tyramide signal amplification for low-abundance targets

Following a methodology similar to that described for other antibodies, researchers should evaluate staining intensity on a scale of 0-3 (negative to high) and assess the extent of staining as a percentage of positively stained cells (0-3 for 0%, 1-25%, 26-50%, and 51-100%) .

What approaches can be used to validate ASK17 antibody specificity in Arabidopsis thaliana?

Advanced validation approaches include:

  • Genetic validation: Test antibody in ASK17 knockout/knockdown lines (T-DNA insertion lines, CRISPR-Cas9 edited plants)

  • Recombinant protein controls: Use purified ASK17 protein as positive control

  • Epitope mapping: Identify the specific binding region to predict potential cross-reactivity

  • Mass spectrometry validation: Confirm identity of immunoprecipitated proteins

  • Bioinformatic analysis: Compare epitope sequence conservation across ASK family

This multi-faceted validation approach resembles methods used for other antibodies in research contexts, where specificity is critical for accurate interpretation of results .

How can researchers employ computational approaches to improve ASK17 antibody specificity?

Recent advances in computational biology offer powerful tools for enhancing antibody specificity:

  • Binding mode identification: Computational models can identify distinct binding modes associated with specific ligands, allowing prediction of antibody variants with customized specificity profiles

  • Epitope prediction: In silico analysis of ASK17 structure to identify unique surface-exposed regions

  • Cross-reactivity prediction: Identify sequence homology with other ASK family members to avoid targeting conserved regions

  • Structure-based optimization: Use protein structure modeling to refine antibody design

Biophysics-informed models trained on experimental data can be particularly valuable, enabling prediction and generation of specific variants beyond those observed in experiments .

What are the considerations for using ASK17 antibodies in multiplex immunostaining protocols?

For multiplex protocols involving ASK17:

  • Antibody compatibility: Select primary antibodies from different host species to avoid cross-reactivity

  • Sequential staining: Consider sequential rather than simultaneous application when using multiple antibodies

  • Spectral overlap: Choose fluorophores with minimal spectral overlap for immunofluorescence

  • Signal-to-noise optimization: Balance sensitivity and background through careful titration

  • Controls: Include single-stain controls to verify specificity in the multiplex context

How can researchers address inconsistent ASK17 antibody staining patterns?

Inconsistent staining may be addressed through:

  • Fixation optimization: Test different fixation protocols to preserve epitope accessibility

  • Antigen retrieval adjustment: Modify pH, buffer composition, or duration of antigen retrieval

  • Tissue permeabilization: Optimize detergent concentration and incubation time

  • Antibody concentration titration: Test serial dilutions to identify optimal concentration

  • Incubation conditions: Adjust temperature, time, and buffer composition

Researchers might apply systematic troubleshooting approaches similar to those used for other antibodies, where staining intensity is evaluated across multiple experimental conditions .

What strategies can help resolve contradictory results when using different ASK17 antibody clones?

When facing contradictory results:

  • Epitope mapping: Determine if different antibodies recognize distinct epitopes on ASK17

  • Validation in knockouts: Test all antibodies in ASK17 knockout lines

  • Orthogonal methods: Verify results using non-antibody methods (e.g., mRNA expression)

  • Cross-reactivity assessment: Evaluate each antibody for recognition of other ASK family members

  • Post-translational modification sensitivity: Determine if results differ due to sensitivity to protein modifications

This approach parallels methods used to resolve contradictions with other antibodies in research settings .

What are the best practices for quantifying ASK17 expression levels using antibody-based methods?

For rigorous quantification:

  • Standard curves: Use recombinant ASK17 protein to generate standard curves for absolute quantification

  • Normalization controls: Include loading controls (housekeeping proteins) for relative quantification

  • Technical replicates: Perform at least three technical replicates per biological sample

  • Quantitative image analysis: Use appropriate software for densitometry or fluorescence intensity measurement

  • Statistical validation: Apply appropriate statistical tests to determine significance of observed differences

How can researchers differentiate between specific and non-specific binding when using ASK17 antibodies?

To distinguish specific from non-specific binding:

  • Competitive inhibition: Pre-incubate antibody with immunizing peptide

  • Knockout controls: Compare staining in wildtype versus ASK17 knockout tissues

  • Isotype controls: Use non-specific antibodies of the same isotype and concentration

  • Cross-adsorption: Pre-adsorb antibody with related proteins to remove cross-reactive antibodies

  • Titration analysis: Examine dose-dependent binding patterns

How are ASK17 antibodies being utilized in systems biology approaches to understand plant signaling networks?

Advanced systems biology applications include:

  • Protein interactome mapping: Identify all ASK17 binding partners through IP-MS

  • Spatiotemporal expression profiling: Map ASK17 expression across developmental stages and stress conditions

  • Post-translational modification mapping: Identify how modifications regulate ASK17 function

  • Network modeling: Integrate ASK17 data into computational models of plant signaling networks

  • Single-cell analysis: Examine cell-type specific expression patterns

These approaches leverage antibody-based methods to generate comprehensive datasets for systems-level understanding of ASK17 function.

What are the emerging technologies for enhancing ASK17 antibody specificity and sensitivity?

Cutting-edge technologies include:

  • Machine learning-based antibody design: Computational prediction of optimal epitopes and binding characteristics

  • Single-domain antibodies: Smaller antibody fragments with enhanced tissue penetration

  • Proximity ligation assays: Detecting protein interactions with greatly enhanced sensitivity

  • Super-resolution microscopy: Nanoscale localization of ASK17 within cellular compartments

  • Biophysics-informed modeling: Identifying multiple binding modes to design antibodies with customized specificity profiles

How can computational modeling improve ASK17 antibody design and application?

Advanced computational approaches include:

  • Sequence-based epitope prediction: Identifying unique regions of ASK17 as antibody targets

  • Structural modeling: Predicting antibody-antigen interaction based on 3D structures

  • Biophysics-informed models: Training models on experimental data to predict novel antibody variants with desired specificity

  • Multiple binding mode analysis: Identifying distinct binding modes associated with specific ligands

  • Cross-reactivity prediction: Computational screening for potential off-target binding

Recent advances demonstrate that "biophysics-informed models trained on experimental data can predict and generate specific variants beyond those observed in experiments," suggesting potential applications for designing ASK17 antibodies with customized specificity profiles .

What role might ASK17 play in plant stress responses, and how can antibodies help elucidate these mechanisms?

Investigating ASK17 in stress responses:

  • Stress-induced expression changes: Use antibodies to quantify ASK17 protein levels under various stresses

  • Post-translational modifications: Develop modification-specific antibodies to track regulatory changes

  • Protein-protein interaction dynamics: Apply co-IP to identify stress-specific binding partners

  • Subcellular relocalization: Track ASK17 movement during stress responses

  • Tissue-specific expression: Map expression patterns across tissues during stress adaptation

How does ASK17 antibody performance compare with antibodies targeting other ASK family members?

When comparing ASK family antibodies:

  • Epitope conservation: Assess degree of sequence similarity at antibody binding sites

  • Cross-reactivity profiles: Systematically test each antibody against all ASK family members

  • Performance metrics: Compare sensitivity, specificity, and signal-to-noise ratios

  • Application versatility: Evaluate performance across different experimental techniques

  • Reproducibility: Compare lot-to-lot variation between different ASK antibodies

ASK Family MemberUniprot IDMolecular WeightKey Distinguishing Features
ASK17Q9SL65~18 kDaSpecific to Arabidopsis thaliana
ASK15Q1PEL7~18 kDa76% sequence identity with ASK17
ASK19O81058~19 kDa65% sequence identity with ASK17
ASK11O49484~18 kDaDifferent tissue expression pattern
ASK7Q9LSY0~18 kDaDistinct F-box protein binding profile

What can be learned from antibody development strategies used for other plant proteins?

Lessons from other plant protein antibodies:

  • Epitope selection strategies: Identify most successful approaches for plant-specific antigens

  • Validation methodologies: Adapt rigorous validation frameworks from other fields

  • Production systems: Compare efficacy of different expression systems for plant protein antigens

  • Application optimization: Adapt protocols developed for other challenging plant targets

  • Cross-species reactivity: Evaluate conservation of epitopes across plant species for broader utility

Researchers can apply biophysics-informed models similar to those described for other antibodies, identifying distinct binding modes to design ASK17 antibodies with improved specificity and reduced cross-reactivity .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.